STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Clinical trials for STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test may tell who needs extra cancer treatment after bladder surgery
Disease control Recruiting nowThis study looks at whether a simple blood test can find leftover cancer DNA after bladder or urinary tract cancer surgery. About 992 people will get either standard immunotherapy (nivolumab) or a combination of two immunotherapies (nivolumab and relatlimab) based on their blood …
Matched conditions: STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Scientists hunt for clues to cancer drug resistance in new study
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 1,500 people with prostate or bladder cancer that has returned or spread. Researchers will analyze the samples to find genetic changes and other markers that explain why some cancers stop responding to treatment. The goal is to di…
Matched conditions: STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC